Summary: The Neurology Minute podcast delivers a brief daily summary of what you need to know in the field of neurology, the latest science focused on the brain, and timely topics explored by leading neurologists and neuroscientists. From the American Academy of Neurology and hosted by Stacey Clardy, MD, PhD, FAAN, with contributions by experts from the Neurology journals, Neurology Today, Continuum, and more.
In the fourth part of an extended series with interviewer Dr. David Lapides, Dr. Jon Stone discusses diagnosis of nonepileptic spells.
Dr. Rae Bacharach discusses interpretation of antibody titers in paraneoplastic and autoimmune neuroantibody testing.
Dr. Fabio Nascimento discusses upward gaze palsy
Dr. Julie Silver discusses the main takeaways from her paper on understanding and addressing gender equity for women in neurology.
Dr. Steve Pearson give the main takeaways from his update discussion with Dr. Gordon Smith on drug pricing.
In the third part of an extended series with interviewer Dr. David Lapides, Dr. Jon Stone discusses diagnosis of functional movement disorders.
Dr. Fabio Nascimento discusses clinical pearls on oculopalatal myoclonus.
Dr. Mike R. Wilson continues with more takeaways from his talk on next gen sequencing diagnosis of encephalitis.
Dr. Amanda Guidon and Dr. Divyanshu Dubey discuss the main takeaways from the discussion on checkpoint inhibitor associated neuropathy.
Dr. Mike R. Wilson the takeaways from his discussion on clinical metagenomic sequencing for diagnosis of meningitis and encephalitis.
Dr. Jon Stone discusses the myth that function neurologic disorders are a diagnosis of exclusion in the 2nd of a 13-part series.
Dr. Jon Stone discusses who is susceptible to functional neurologic disorders in the first of a 13-part series.
Dr. Jonathan Graff-Radford discusses highlights of the upcoming AAN Fall Conference in Las Vegas.
Dr. Jonathan Newmark discusses the main takeaways on acute nerve agent poisoning.
Dr. Jan Claassen discusses the main takeaways from his NEJM paper on detection of brain activation in unresponsive patients with acute brain injury.